U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"One of the greatest labor saving inventions of today is tomorrow!"

Vincent T. Floss

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 544/112 - Triazine ring


Subclass of Class 544 - Organic compounds -- part of the class 532-570 series
Definition: Compounds in which the additional hetero ring is six-membered
No. of patents: 107
Last issue date: 09/16/2008


1      
NumberTitleIssue Date
74255613-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The ar...
09/16/2008
7371750Compounds and compositions as protein kinase inhibitors
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or d...
05/13/2008
7329658Cannabinoid receptor ligands and uses thereof
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein. ...
02/12/2008
7307077Heterocyclic compound and antitumor agent containing the same as effective ingredient
The present invention relates to heterocyclic compounds represented by the formula I or pharmaceutically acceptable salts thereof and antitumor agents containing the heterocyclic compounds as effective components: wherein X...
12/11/2007
7304050Antibacterial agents
Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I a...
12/04/2007
7217714CCR5 modulators
Compounds of Formula 1 [Region α]−[Region β]−[Region γ]−[Region δ]   (I) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and m...
05/15/2007
7160883Pyrrolo-triazine aniline compounds useful as kinase inhibitors
Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R1, R2, R3, R4, R...
01/09/2007
7157456Substituted oxazolidinones and their use in the field of blood coagulation
The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of the general formula (I) processes for their preparation and their use as medicinally active compounds for the prophylaxi...
01/02/2007
7153853Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
The present invention relates to heterocyclic compounds represented by the formula I wherein X represents nitrogen atom or CH; R1 represents halogen atom or hydroxyl; R2 represents hydrogen ...
12/26/2006
7141588N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
The present invention provides antibacterial agents having the formulae I, II, and III described herein. ...
11/28/2006
7141570N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
The present invention provides antibacterial agents having the formula I described herein. ...
11/28/2006
7129259Halogenated biaryl heterocyclic compounds and methods of making and using the same
The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having at least one halogenated hydrocarbon moiety, a biaryl moiet...
10/31/2006
7094900N-Aryl-2-oxazolidinones and their derivatives
The present invention provides antibacterial agents of formula I described herein. ...
08/22/2006
7071189Heterocyclic compound and antitumor agent containing the same as active ingredient
The present invention relates to heterocyclic compounds represented by the formula I or pharmaceutically acceptable salts thereof and antitumor agents containing the heterocyclic compounds as effective components:
07/04/2006
7022808Polymers
A polymer having a plurality of 5–6 membered unsaturated rings which may be the same or different, linked together by way of linker chains to form a backbone, at least some of said 5–6 membered unsaturated rings carrying a ligand. Polymers of this nature can act...
04/04/2006
7022705Isoxazoline derivatives useful as antimicrobials
Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein, for example, HET is an N-linked 5-membered, fully or partially u...
04/04/2006
6998483Process for the preparation of sulphonamide-substituted imidazotriazinones
The present invention relates to a process for the preparation of sulphonamide-substituted imidazotriazinones of the general formula (I) characterized in that compounds of the formula (II)
02/14/2006
6974812Benzamide inhibitors of the P2X7 Ereceptor
The present invention provides benzamide inhibitors of the P2X7 receptor of the formula: wherein R1-R3 are as defined herein. The compounds of the invention are useful in the treatment ...
12/13/2005
6969726Biaryl heterocyclic compounds and methods of making and using the same
The present invention relates generally to the field of anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having both a biaryl moiety and at least one heterocylic moiety th...
11/29/2005
6943158Diazinopyrimidines
Compounds of formula I are p38 inhibitors: or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or alkyl; R2 alkyl, h...
09/13/2005
6919329N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives
The present invention provides antibacterial agents having the formulae I, II, and III described herein. ...
07/19/2005
6908916C-5 modified indazolylpyrrolotriazines
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HE...
06/21/2005
6894046IL-5 inhibiting 6-azauracil derivatives
The present invention is concerned with the compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein p is 0 to 4; X is O, S, NR5
05/17/2005
68909222-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizi...
05/10/2005
6878708Imidazotriazinones and the use thereof
Novel imidazotriazinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed. ...
04/12/2005
6867207IL-5 inhibiting 6-azauracil derivatives
The present invention is concerned with the compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, p and q are 0, 1, 2, 3 or 4 and q is also 5...
03/15/2005
6803365Imidazo[1,3,5]triazinones and the use thereof
The invention relates to imidazo[1.3.5]triazinones, a method for their production and methods of use, in particular as inhibitors of cyclic GMP metabolizing phosphodiesterases. ...
10/12/2004
6777551Process for the preparation of sulphonamide-substituted imidazotriazinones
The present invention relates to a process for the preparation of sulphonamide-substituted imidazotriazinones of the general formula (I) characterized in that compounds of the formula (II)
08/17/2004
6774127Pyrazole and pyrazoline substituted compounds
Novel pyridyl and pyrimidinyl substituted pyrazole and pyrazoline compounds and compositions for use in therapy. ...
08/10/2004
67437926-azauracil derivatives as IL-5 inhibitors
The present invention is concerned with the use of compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein p represents 0, 1, 2 or 3; q r...
06/01/2004
6683081Triazolotriazinones and the use thereof
The invention relates to novel triazolotriazinones of the general formula (I), to a method for their production and to the pharmaceutical use thereof. ##STR1##...
01/27/2004
6680315Triazine compounds
This invention relates to triazine compounds of formula (I): ##STR1## R1 is, aryl, ##STR2## or heteroaryl; each of R2, R4, and R5, independently, is Rc, halogen, nitro, nitroso, cyano, azide, isothion...
01/20/2004
6670357Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
Methods of treating one or more conditions associated with p38 kinase activity are disclosed comprising administering to a patient in need thereof at least one compound having the formula (I): ##STR1## or a pharmaceutically acceptable salt, prodrug, or so...
12/30/2003
6642381Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B....
11/04/2003
6620812Sulfamoyl compounds and agricultural and horticultural fungicides
A sulfamoyl compound of the general formulae (1): ##STR1## wherein R1 and R2 are each independently C1-4 alkyl, or R1 and R2 together are C4-6 alkylene or C4-6 alkyleneoxy, Y ...
09/16/2003
6610677Pyrazole compounds useful as protein kinase inhibitors
This invention describes novel pyrazole compositions comprising a pharmaceutically acceptable carrier and a compound of formula VIII: ##STR1## wherein Z1 is N or C--R9, Z2 is N or CH, and Z3 is N or C--Rx
08/26/2003
6608004Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones
The invention relates to novel substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones of the general formula (I), ##STR1## in which Q1, Q2, R1, R2, R3, R4, R5 and R6 are ea...
08/19/2003
6498158Il-5 inhibiting 6-azauracil derivatives
The present invention is concerned with the compounds of formula ##STR1## the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein p is 0 to 3; q is 0 to 4; --A--B-- represents --(CH2...
12/24/2002
6476030Pyrazolo-triazine derivatives as ligands for GABA receptors
Compounds according to Formula (I): ##STR1## or a salt or prodrug thereof, have good affinity as ligands for the alpha2 and/or alpha3 subunit of the human GABAA receptor and are useful for treatment of disorders of the central nervous system, i...
11/05/2002
6469001IL-5 inhibiting 6-azauracil derivatives
The present invention is concerned with the compounds of formula ##STR1## the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein p is 0 to 3; q is 0 to 5; --A--B-- is --(CH2)r
10/22/2002
1      
 
Sign InRegister
Username  
Password   
forgot password?